Genmab A (GMAB) Operating Expenses: 2018-2020
Historic Operating Expenses for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to -$441.2 million.
- Genmab A's Operating Expenses fell 46.94% to -$124.56 in Q2 2021 from the same period last year, while for Jun 2021 it was -$381.59, marking a year-over-year decrease of 100.00%. This contributed to the annual value of -$441.2 million for FY2020, which is 55.52% down from last year.
- Latest data reveals that Genmab A reported Operating Expenses of -$441.2 million as of FY2020, which was down 55.52% from -$283.7 million recorded in FY2019.
- Genmab A's 5-year Operating Expenses high stood at -$181.9 million for FY2018, and its period low was -$441.2 million during FY2020.
- For the 3-year period, Genmab A's Operating Expenses averaged around -$302.3 million, with its median value being -$283.7 million (2019).
- Data for Genmab A's Operating Expenses shows a maximum YoY tumbled of 55.99% (in 2019) over the last 5 years.
- Yearly analysis of 3 years shows Genmab A's Operating Expenses stood at -$181.9 million in 2018, then slumped by 55.99% to -$283.7 million in 2019, then tumbled by 55.52% to -$441.2 million in 2020.